Weekly Companion Animal News: November 10, 2025

New SoundByte: EN Gastroenteric®

Purina® Pro Plan® Veterinary Diets EN Gastroenteric® Canine Formulas are highly digestible to promote optimal nutrient absorption. Made with high-quality ingredients, including coconut oil or medium-chain triglyceride (MCT) vegetable oil, which provide MCTs (6.1 – 17.3% of fat), an easily digested source of energy. Find more in the SoundByte from Veterinary Advantage

Bionet America launches cloud-connected monitoring system

Veterinary medical device firm Bionet introduced the O’Pet Curv, a cloud-connected wireless monitoring system which allows veterinarians to track up to six patients simultaneously with automated reporting of vital trends, ECG waveforms and comprehensive patient management. The waterproof sensor provides up to 40 hours of battery life.

Dechra launches Solovecin in US, injectable antibiotic for skin infections

Dechra announced the U.S. launch of Solovecin (cefovecin sodium), a long-acting injectable antibiotic for the treatment of skin infections in companion animals. For dogs, it is indicated for the treatment of secondary superficial pyoderma, abscesses, and wounds caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).  For cats, it is indicated for wounds and abscesses caused by susceptible strains of Pasteurella multocida.

British vet groups call for ‘a more considered approach’ to small-animal parasiticides

Three British veterinary groups, including the British Veterinary Association, are calling for a more considered approach to the use of small-animal parasiticides, citing “increasing evidence that some parasiticides are contaminating the environment, including through wastewater from homes, animals entering waterways outdoors, excretion in faeces and urine, and residues in pet fur.” In a policy position, the groups offered 36 recommendations for further research.

Phibro launches Restoris for treatment of periodontal disease in dogs

Phibro Animal Health Corporation announced the launch of Restoris piezoelectric dental gel, intended to support the natural healing response of periodontal tissues and restore healthy tooth attachment. Restoris is applied into periodontal pockets using a prefilled syringe and then cured with supplied UV light. Studies show that 80–90% of dogs over the age of three have some component of periodontal disease, according to the company.

Medetomidine linked to mass overdose in Baltimore

Medetomidine, a sedative and analgesic medication primarily used in veterinary medicine, was found in two drug samples collected following a mass overdose in Baltimore’s Penn North community. Eleven people reportedly overdosed on Oct. 8, and seven were treated at the hospital. The sedative is often mixed with the synthetic opioid fentanyl and can make overdoses harder to reverse.

Frailty study on Rottweilers challenges thinking about spay/neuter

The “Exceptional Aging in Rottweilers Study,” published recently in Scientific Reports, seeks to better understand aging and disease resistance through the study of the oldest-living Rottweilers. The findings extend the investigators’ recently published work on frailty that are challenging conventional thinking about the health consequences associated with spaying or neutering companion dogs.

Daewoong enters animal drug market with SGLT-2 inhibitor for dogs

Seoul, South Korea-based Daewoong Pharmaceutical applied for approval from Korea’s Animal and Plant Quarantine Agency for EnvloPet, a pet diabetes drug adapted from its human treatment Envlo (Enavogliflozin). EnvloPet is said to be the world’s first SGLT-2 inhibitor for dogs, designed to lower blood sugar by excreting glucose through urine. Daewoong said it plans to officially enter the animal drug market beginning with EnvloPet.

Accreditation review scheduled for new Arkansas veterinary school

Lyon College School of Veterinary Medicine in Cabot, Arkansas, announced it has officially been notified of its comprehensive accreditation review scheduled for summer 2026 by the American Veterinary Medical Association Council on Education. LCSVM announced its four-year Doctor of Veterinary Medicine curriculum as part of its development, with classes scheduled to start in 2027.